Mercer Global Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.9M Buy
101,092
+11,334
+13% +$1.22M 0.02% 349
2025
Q1
$9.05M Buy
89,758
+15,883
+21% +$1.6M 0.02% 386
2024
Q4
$6.6M Sell
73,875
-9,459
-11% -$845K 0.02% 466
2024
Q3
$7.01M Buy
83,334
+24,365
+41% +$2.05M 0.02% 411
2024
Q2
$4.55M Buy
58,969
+888
+2% +$68.5K 0.01% 477
2024
Q1
$3.98M Buy
58,081
+9,280
+19% +$636K 0.01% 526
2023
Q4
$2.82M Buy
48,801
+955
+2% +$55.2K 0.01% 629
2023
Q3
$2.53M Buy
47,846
+15,588
+48% +$823K 0.01% 628
2023
Q2
$1.75M Buy
32,258
+4,616
+17% +$250K 0.01% 769
2023
Q1
$1.38M Sell
27,642
-1,765
-6% -$88.3K 0.01% 797
2022
Q4
$1.36M Buy
29,407
+3,767
+15% +$174K 0.01% 799
2022
Q3
$993K Buy
25,640
+751
+3% +$29.1K 0.01% 845
2022
Q2
$927K Sell
24,889
-240
-1% -$8.94K 0.01% 879
2022
Q1
$1.11M Sell
25,129
-654
-3% -$29K 0.01% 853
2021
Q4
$1.1M Buy
25,783
+1,967
+8% +$83.5K 0.01% 845
2021
Q3
$1.03M Buy
23,816
+5,569
+31% +$242K 0.01% 843
2021
Q2
$780K Buy
18,247
+2,207
+14% +$94.3K 0.01% 949
2021
Q1
$620K Buy
16,040
+5,077
+46% +$196K 0.01% 986
2020
Q4
$394K Sell
10,963
-472
-4% -$17K ﹤0.01% 962
2020
Q3
$437K Buy
11,435
+467
+4% +$17.8K 0.01% 822
2020
Q2
$385K Sell
10,968
-181
-2% -$6.35K 0.01% 770
2020
Q1
$364K Buy
11,149
+642
+6% +$21K 0.01% 752
2019
Q4
$475K Sell
10,507
-229
-2% -$10.4K 0.01% 752
2019
Q3
$436K Buy
10,736
+548
+5% +$22.3K 0.01% 742
2019
Q2
$438K Sell
10,188
-100
-1% -$4.3K 0.01% 734
2019
Q1
$395K Buy
+10,288
New +$395K 0.01% 723